Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Technology Scientific & Technical Instruments
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE

PR Newswire November 3, 2022

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS

PR Newswire November 1, 2022

BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND

PR Newswire November 1, 2022

Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference

PR Newswire October 31, 2022

New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

PR Newswire October 18, 2022

BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

PR Newswire October 12, 2022

BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS

PR Newswire October 11, 2022

BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS

PR Newswire October 10, 2022

BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES

PR Newswire October 6, 2022

Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments

PR Newswire September 26, 2022

MAURICE FLEX(TM) icIEF ANALYSIS ADDS FRACTIONATION, ENABLING MASS SPEC PEAK CHARACTERIZATION

PR Newswire September 21, 2022

BIO-TECHNE ISSUES 2022 CORPORATE SUSTAINABILITY REPORT

PR Newswire September 19, 2022

BIO-TECHNE PRESENTS INITIAL DATA ON SJÖGREN'S SYNDROME MONITORING ASSAY

PR Newswire September 8, 2022

BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE

PR Newswire September 6, 2022

BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT

PR Newswire September 1, 2022

BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE

PR Newswire August 30, 2022

BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE

PR Newswire August 29, 2022

MAURICE icIEF ESTABLISHED AS A GREEN METHOD FOR CHARACTERIZATION OF AAV IDENTITY AND STABILITY

PR Newswire August 25, 2022

BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST

PR Newswire August 24, 2022

BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX® DATA ANALYSIS SOFTWARE

PR Newswire August 18, 2022